Deciphera Pharmaceuticals Stock (NASDAQ: DCPH) stock price, news, charts, stock research, profile.
Open | $25.470 |
Close | $25.470 |
Volume / Avg. | 851.175K / 1.696M |
Day Range | 25.450 - 25.480 |
52 Wk Range | 9.900 - 25.550 |
Market Cap | $2.201B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 86 |
Short Interest | 9.43% |
Days to Cover | 1.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Deciphera Pharmaceuticals (NASDAQ: DCPH) through any online brokerage.
Other companies in Deciphera Pharmaceuticals’s space includes: MoonLake (NASDAQ:MLTX), Fusion Pharmaceuticals (NASDAQ:FUSN), Agios Pharmaceuticals (NASDAQ:AGIO), Dyne Therapeutics (NASDAQ:DYN) and ACADIA Pharmaceuticals (NASDAQ:ACAD).
The latest price target for Deciphera Pharmaceuticals (NASDAQ: DCPH) was reported by Guggenheim on Tuesday, April 30, 2024. The analyst firm set a price target for 0.00 expecting DCPH to fall to within 12 months (a possible -100.00% downside). 15 analyst firms have reported ratings in the last year.
The stock price for Deciphera Pharmaceuticals (NASDAQ: DCPH) is $25.45 last updated May 20, 2024 at 4:03 PM EDT.
There are no upcoming dividends for Deciphera Pharmaceuticals.
Deciphera Pharmaceuticals’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Deciphera Pharmaceuticals.
Deciphera Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.